StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) shareholders

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.06−0.44 (-12.57%)

Close on Nov 18, 2026Market cap $62.83KP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 148M shares
Institutional holders
2
1 new, 3 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Timothy Mark Dyer19,165,7149.01%13D (active) amendmentSep 2, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ADXNValueChange% of portfolio
UBS Group AG470.00%$268New0.00%
SBI Securities Co., Ltd.10.00%$6–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202620M0.0%1 / 00 / 30M0M
Q1 202640M0.0%0 / 10 / 10M0M
Q4 202550M0.0%1 / 12 / 00M0M
Q3 202540M0.0%1 / 00 / 20M0M
Q2 202550M0.0%1 / 01 / 10M0M
Q1 202550M0.0%0 / 13 / 00M0M
Q4 202450M0.0%3 / 20 / 10M0M
Q3 202430M0.0%1 / 11 / 00M0M
Q2 202420M0.0%1 / 10 / 00M0M
Q1 202410M0.0%1 / 00 / 30M0M
Q4 202330M0.1%3 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Timothy Mark DyerCHIEF EXECUTIVE OFFICER, Director435,1920.29%Nov 13, 2026
Roger MillsCHIEF MEDICAL OFFICER, Director785,9760.53%Nov 13, 2026
Lenaic Nathanael TeyssedouPRINCIPAL ACCOUNTING OFFICER––Nov 13, 2026
Mikhail KalinichevHEAD OF TRANSLATIONAL SCIENCE0–Sep 4, 2026
Vincent Michael LawtonDirector2,507,9871.70%Nov 16, 2026
Raymond George HillDirector0–Nov 16, 2026
Jason Raleigh NunnDirector219,5610.15%Nov 13, 2026
Isaac MankeDirector219,5610.15%Nov 13, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Jason Raleigh Nunn
Director
Sep 2, 2026Award+219,561––219,561
Jason Raleigh Nunn
Director
Sep 2, 2026Returned to company−219,561––0
Timothy Mark Dyer
CHIEF EXECUTIVE OFFICER, Director
Sep 2, 2026Returned to company−16,413,787––435,192
Timothy Mark Dyer
CHIEF EXECUTIVE OFFICER, Director
Sep 2, 2026Award+16,413,787––16,848,979
Mikhail Kalinichev
HEAD OF TRANSLATIONAL SCIENCE
Sep 2, 2026Returned to company−306,765––0
Mikhail Kalinichev
HEAD OF TRANSLATIONAL SCIENCE
Sep 2, 2026Award+306,765––306,765
Raymond George Hill
Director
Sep 2, 2026Returned to company−1,365,532––0
Raymond George Hill
Director
Sep 2, 2026Award+1,365,532––1,365,532
Roger Mills
CHIEF MEDICAL OFFICER, Director
Sep 2, 2026Award+392,837––785,976
Roger Mills
CHIEF MEDICAL OFFICER, Director
Sep 2, 2026Returned to company−392,837––393,139
Vincent Michael Lawton
Director
Sep 2, 2026Award+2,507,487––2,507,987
Vincent Michael Lawton
Director
Sep 2, 2026Returned to company−2,507,487––500
Isaac Manke
Director
Sep 2, 2026Award+219,561––219,561
Isaac Manke
Director
Sep 2, 2026Returned to company−219,561––0

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.6
At 0M shares a day
Change since last report
+6.4%
From 0M shares
Short volume, 20 days
55.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Addex Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 432,110 shares on Aug 24, 2026 over the last 90 days.

See a number that looks wrong?